Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2013 FY- Text added to 2014 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
ABC, amid, Ampal, antiviral, Aran, Arel, Bachelor, background, Bashan, BCOM, Beer, Ben, Bezeq, Bunkersec, CA, career, Cheyne, CMC, Consul, Datasphere, diagnostic, dissolved, Dobroslav, Doron, Ebola, Economist, Eiland, entrepreneur, Fain, Fellowship, Fertility, Francisco, Galaxy, Gamatronic, Giora, Gold, Gurion, HaCharoshet, hasthree, Hemophilia, Hillel, IDB, IGLD, IL, infertility, insulin, InterVision, Jonathan, LeumiStart, male, Matrix, Melamed, Micronet, Nagar, Newton, Oded, ofthe, Oshadi, Osnat, passthough, PhD, PowerDsine, Pretium, Priortech, Propulsion, QBI, Rabin, repaid, resale, RoundAllotted, Sabby, San, Schapiro, SciGen, SciVac, SDS, Shalev, Sheba, Sheva, Shlomo, Stanford, Steering, strong, TCB, TheGroup, Turgeman
Removed:
accepted, achieved, addressing, ADR, adult, alia, allocate, analyst, analyzed, announcement, anticipation, assumed, AstraZeneca, Bancorp, Bedford, Bicifadine, Bifeprunox, Binghamton, blind, BLZ, British, Building, capable, Cariprazine, carlo, cartilage, Chaikin, Chartered, cognition, commitment, committed, computing, consistency, Continuation, creating, creation, Dainippon, datamonitor, Dauphine, declined, dedicated, deputy, derive, deterioration, diabetic, differentiating, dismissal, distressed, double, DOV, earn, effecting, efficient, electrical, Eli, Emblaze, Enalaprilat, engineering, Euronext, Europort, eventually, explained, facilitated, fluid, formally, FORTY, fourth, French, guide, Harel, HCV, healthcare, hypertension, improving, individually, ING, INGA, inhibitor, inter, Inventech, irrevocably, IVTC, Jaffray, jointly, laboratory, landlord, launch, legally, letter, library, Lilly, LSE, Lurasidone, mandatory, Manova, MDMD, measure, Mediamind, median, Mega, MGOR, monetization, monte, multinational, natural, Nessuah, neuropathic, NFI, NiCure, nimh, NOL, norepinephrine, notably, olanzapine, Orange, overcome, Park, peripheral, pfizer, Pharma, Piper, play, PO, preventing, quetiapine, randomized, ranging, recognizing, relieving, replenishing, retrospectively, reuptake, revealed, reversing, risperidone, route, Russel, Sagit, sector, separated, serotonin, SGPA, Shalom, sharp, shortly, skin, SNRI, Solvay, Somekh, specialty, square, stipulated, structured, sublicensed, Sumitomo, synovial, Tagor, tenant, TGCP, trademark, transition, Treasurer, turnaround, typical, unchanged, unlisted, unvested, USA, Waterhouse, Wilmington, Zannex, ziprasidone
Valuein 2013 FY filing- Value in 2014 FY filing
Original filings
Filing view